ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

0.09% CPC + Zinc Lactate Mouthwash

Its studies are led by Colgate Palmolive.

Furthest: phase 4, since Oct 7, 20261 company-led study, 1 open or runningNext primary completion: Dec 15, 2026 (phase 4)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Colgate Palmolive11 open or runningphase 4since Oct 7, 2026Oct 7, 2026Dec 15, 2026phase 4 · NCT07880509

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Oct 7, 2026First study: phase 4 study in Bacterial ContaminationFirst studyNCT07880509 · 60 planned

Ahead

  1. Dec 15, 2026Primary completion: phase 4 study in Bacterial ContaminationNCT07880509

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 1 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07880509Bacterial Contamination4Not yet recruitingDec 15, 202660

How it is read

Names in the registry

  • “0.09% CPC + Zinc Lactate Mouthwash”, 1 entry

Conditions, from the studies’ own filings

    First seen by our ledger Nov 13, 2026.

    What this can’t show

    • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
    • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
    • Primary completion dates are the sponsors’ estimates and often move.
    • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.